Index by author
Sablot, D.
- FELLOWS' JOURNAL CLUBInterventionalYou have accessPredictors of Favorable Outcome after Endovascular Thrombectomy in MRI: Selected Patients with Acute Basilar Artery OcclusionM. Mahmoudi, C. Dargazanli, F. Cagnazzo, I. Derraz, C. Arquizan, A. Wacogne, J. Labreuche, A. Bonafe, D. Sablot, P.H. Lefevre, G. Gascou, N. Gaillard, C. Scott, V. Costalat and I. MourandAmerican Journal of Neuroradiology September 2020, 41 (9) 1670-1676; DOI: https://doi.org/10.3174/ajnr.A6741
The authors analyzed consecutive MR imaging–selected patients with acute basilar artery occlusions endovascularly treated within the first 24 hours after symptom onset. Successful and complete reperfusion was defined as modified TICI scores 2b–3 and 3, respectively. Outcome at 90 days was analyzed. One hundred ten patients were included. In 10 patients, endovascular treatment was aborted for failed proximal/distal access. Overall, successful reperfusion was achieved in 81.8% of cases. At 90 days, favorable outcome was 31.8%, with a mortality rate of 40.9%; the prevalence of symptomatic intracranial hemorrhage within 24 hours was 2.7%. The median time from symptom onset to groin puncture was 410 minutes. In this series of MR imaging–selected patients with acute basilar artery occlusions, complete reperfusion was the strongest predictor of a good outcome. Lower pretreatment NIHSS, the presence of posterior communicating artery collateral flow, the absence of atrial fibrillation, and intravenous thrombolysis administration were associated with favorable outcome.
Sachs, J.R.
- Pediatric NeuroimagingYou have accessInternal Auditory Canal Diverticula among Pediatric Patients: Prevalence and Assessment for Hearing Loss and Anatomic AssociationsP.M. Bunch, M.E. Zapadka, C.M. Lack, E.P. Kiell, D.J. Kirse and J.R. SachsAmerican Journal of Neuroradiology September 2020, 41 (9) 1712-1717; DOI: https://doi.org/10.3174/ajnr.A6691
Sakka, L.
- PediatricsYou have accessAssessment of Maturational Changes in White Matter Anisotropy and Volume in Children: A DTI StudyG. Coll, E. de Schlichting, L. Sakka, J.-M. Garcier, H. Peyre and J.-J. LemaireAmerican Journal of Neuroradiology September 2020, 41 (9) 1726-1732; DOI: https://doi.org/10.3174/ajnr.A6709
Sato, N.
- FELLOWS' JOURNAL CLUBHead & NeckOpen AccessMRI Findings of Immune Checkpoint Inhibitor–Induced Hypophysitis: Possible Association with FibrosisR. Kurokawa, Y. Ota, W. Gonoi, A. Hagiwara, M. Kurokawa, H. Mori, E. Maeda, S. Amemiya, Y. Usui, N. Sato, Y. Nakata, T. Moritani and O. AbeAmerican Journal of Neuroradiology September 2020, 41 (9) 1683-1689; DOI: https://doi.org/10.3174/ajnr.A6692
This retrospective international multicenter study comprised 20 patients with melanoma who were being treated with immune checkpoint inhibitors and clinically diagnosed with immune checkpoint inhibitor–induced hypophysitis. Three radiologists evaluated the following MR imaging findings: enlargement of the pituitary gland and stalk; homogeneity of enhancement of the pituitary gland; presence/absence of a well-defined poorly enhanced area and, if present, its location, shape, and signal intensity in T2WI; and enhancement pattern in contrast-enhanced dynamic MR imaging. Enlargement of the pituitary gland and stalk was observed in 12 and 20 patients, respectively. Nineteen patients showed poorly enhanced lesions (geographic hypoenhancing lesions) in the anterior lobe, and 11 of these lesions showed hypointensity on T2WI. Thyrotropin deficiency and corticotropin deficiency were observed in 19/20 and 12/17 patients, respectively. The authors conclude that pituitary geographic hypoenhancing lesions in the anterior lobe of the pituitary gland are characteristic and frequent MR imaging findings of immune checkpoint inhibitor–induced hypophysitis.
Savatovsky, J.S.
- NeurointerventionYou have accessFusion Image Guidance for Supra-Aortic Vessel Catheterization in Neurointerventions: A Feasibility StudyA. Feddal, S. Escalard, F. Delvoye, R. Fahed, J.P. Desilles, K. Zuber, H. Redjem, J.S. Savatovsky, G. Ciccio, S. Smajda, M. Ben Maacha, M. Mazighi, M. Piotin and R. BlancAmerican Journal of Neuroradiology September 2020, 41 (9) 1663-1669; DOI: https://doi.org/10.3174/ajnr.A6707
Scaramozza, M.
- Adult BrainYou have accessPatterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS LesionsC. Elliott, D.L. Arnold, H. Chen, C. Ke, L. Zhu, I. Chang, E. Cahir-McFarland, E. Fisher, B. Zhu, S. Gheuens, M. Scaramozza, V. Beynon, N. Franchimont, D.P. Bradley and S. BelachewAmerican Journal of Neuroradiology September 2020, 41 (9) 1584-1591; DOI: https://doi.org/10.3174/ajnr.A6742
Scheer, R.V.
- Head & NeckOpen AccessCOVID-19–Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré SyndromeK.L. Hutchins, J.H. Jansen, A.D. Comer, R.V. Scheer, G.S. Zahn, A.E. Capps, L.M. Weaver and N.A. KoontzAmerican Journal of Neuroradiology September 2020, 41 (9) 1707-1711; DOI: https://doi.org/10.3174/ajnr.A6654
Schmitz, B.L.
- InterventionalYou have accessShape Modification is Common in Woven EndoBridge–Treated Intracranial Aneurysms: A Longitudinal Quantitative Analysis StudyJ. Rosskopf, M. Braun, J. Dreyhaupt, M. Beer, B.L. Schmitz and Y. OzpeynirciAmerican Journal of Neuroradiology September 2020, 41 (9) 1652-1656; DOI: https://doi.org/10.3174/ajnr.A6669
Scott, C.
- FELLOWS' JOURNAL CLUBInterventionalYou have accessPredictors of Favorable Outcome after Endovascular Thrombectomy in MRI: Selected Patients with Acute Basilar Artery OcclusionM. Mahmoudi, C. Dargazanli, F. Cagnazzo, I. Derraz, C. Arquizan, A. Wacogne, J. Labreuche, A. Bonafe, D. Sablot, P.H. Lefevre, G. Gascou, N. Gaillard, C. Scott, V. Costalat and I. MourandAmerican Journal of Neuroradiology September 2020, 41 (9) 1670-1676; DOI: https://doi.org/10.3174/ajnr.A6741
The authors analyzed consecutive MR imaging–selected patients with acute basilar artery occlusions endovascularly treated within the first 24 hours after symptom onset. Successful and complete reperfusion was defined as modified TICI scores 2b–3 and 3, respectively. Outcome at 90 days was analyzed. One hundred ten patients were included. In 10 patients, endovascular treatment was aborted for failed proximal/distal access. Overall, successful reperfusion was achieved in 81.8% of cases. At 90 days, favorable outcome was 31.8%, with a mortality rate of 40.9%; the prevalence of symptomatic intracranial hemorrhage within 24 hours was 2.7%. The median time from symptom onset to groin puncture was 410 minutes. In this series of MR imaging–selected patients with acute basilar artery occlusions, complete reperfusion was the strongest predictor of a good outcome. Lower pretreatment NIHSS, the presence of posterior communicating artery collateral flow, the absence of atrial fibrillation, and intravenous thrombolysis administration were associated with favorable outcome.
Seekins, J.
- EDITOR'S CHOICEPediatricsYou have accessDeep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional StudyJ.L. Quon, W. Bala, L.C. Chen, J. Wright, L.H. Kim, M. Han, K. Shpanskaya, E.H. Lee, E. Tong, M. Iv, J. Seekins, M.P. Lungren, K.R.M. Braun, T.Y. Poussaint, S. Laughlin, M.D. Taylor, R.M. Lober, H. Vogel, P.G. Fisher, G.A. Grant, V. Ramaswamy, N.A. Vitanza, C.Y. Ho, M.S.B. Edwards, S.H. Cheshier and K.W. YeomAmerican Journal of Neuroradiology September 2020, 41 (9) 1718-1725; DOI: https://doi.org/10.3174/ajnr.A6704
This study cohort comprised 617 children (median age, 92 months; 56% males) from 5 pediatric institutions with posterior fossa tumors: diffuse midline glioma of the pons, medulloblastoma, pilocytic astrocytoma, and ependymoma. There were 199 controls. Tumor histology served as ground truth except for diffuse midline glioma of the pons, which was primarily diagnosed by MR imaging. A modified ResNeXt-50-32x4d architecture served as the backbone for a multitask classifier model, using T2-weighted MRI as input to detect the presence of tumor and predict tumor class. Model tumor detection accuracy exceeded an AUC of 0.99 and was similar to that of 4 radiologists. Model tumor classification accuracy was 92% with an F1 score of 0.80. The model was most accurate at predicting diffuse midline glioma of the pons, followed by pilocytic astrocytoma and medulloblastoma. Ependymoma prediction was the least accurate.